Olaplex's 2026 Sales Guidance Downgrade Triggers Stock Plunge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy OLPX?
Source: seekingalpha
- Sales Guidance Downgrade: Olaplex (OLPX) has projected FY26 sales between $414 million and $435 million, with a midpoint of $424.5 million, which falls short of the consensus estimate of $432 million, indicating management's pessimistic outlook for Q1 sales performance.
- EBITDA Margin Warning: The company cautioned that the adjusted EBITDA margin for Q1 will trend significantly below the expected full-year rate, primarily due to front-loaded marketing expenditures that could impact overall profitability.
- Stock Price Plunge: Shares of Olaplex (OLPX) plummeted 21.9% in Thursday morning trading, erasing most of the gains built up for 2026, reflecting strong investor concerns about the company's future prospects.
- CEO Outlook: CEO Amanda Baldwin stated that despite the challenges, the company enters 2026 with a clear path forward and plans to adopt a more balanced and sustainable approach to investment and growth to navigate market changes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OLPX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OLPX
Wall Street analysts forecast OLPX stock price to rise
7 Analyst Rating
2 Buy
4 Hold
1 Sell
Hold
Current: 1.345
Low
1.25
Averages
1.98
High
4.00
Current: 1.345
Low
1.25
Averages
1.98
High
4.00
About OLPX
Olaplex Holdings, Inc. is a foundational health and beauty company. Its Complete Bond Technology works by protecting, strengthening and relinking all three bonds during and after hair services. Its product portfolio includes 23 products that support the hair health needs of its professional hairstylist and consumer communities. It developed its patent-protected bond-building technology, Bis-amino, which works on the molecular level to repair the hair’s disulfide bonds. Leveraging its Bis-amino technology, its two-part salon and at home bond-building treatments are complete bond builders that can repair all three main chemical bonds deep inside the hair: hydrogen, ionic and disulfide bonds. Its OLAPLEX Bond Shaping Technology is a proprietary peptide that penetrates deep into the hair to strengthen, rebuild, and reform curl-shaping disulfide bonds. Its products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Olaplex Holdings Reports Q4 2025 Earnings and Strategic Outlook
- Stable Financial Performance: Olaplex reported full-year net sales of $423 million for 2025, remaining flat year-over-year, yet fourth-quarter sales increased by 4.3% to $105.1 million, indicating strong holiday performance and reflecting the company's stability and potential for future growth.
- Successful Brand Relaunch: The comprehensive brand relaunch resulted in a 7% increase in brand awareness, a 3% improvement in consumer sentiment, and an upward trend in purchase intent, with earned media value rising 14% year-over-year, showcasing Olaplex's effective market promotion and strengthening its position in the competitive beauty industry.
- Strategic Acquisition for Innovation: The acquisition of Purvala Bioscience allows Olaplex to access transformative bio-inspired technologies and enter additional health and beauty verticals, broadening its product line and laying the groundwork for future innovations.
- Cautious Future Outlook: The company expects net sales in 2026 to range from a decline of 2% to an increase of 3%, with adjusted gross profit margins between 71% and 72%, and while facing complexities from packaging rollouts and innovation pipelines, management remains optimistic about sales recovery and emphasizes the effectiveness of marketing investments.
See More
Olaplex's 2026 Sales Guidance Downgrade Triggers Stock Plunge
- Sales Guidance Downgrade: Olaplex (OLPX) has projected FY26 sales between $414 million and $435 million, with a midpoint of $424.5 million, which falls short of the consensus estimate of $432 million, indicating management's pessimistic outlook for Q1 sales performance.
- EBITDA Margin Warning: The company cautioned that the adjusted EBITDA margin for Q1 will trend significantly below the expected full-year rate, primarily due to front-loaded marketing expenditures that could impact overall profitability.
- Stock Price Plunge: Shares of Olaplex (OLPX) plummeted 21.9% in Thursday morning trading, erasing most of the gains built up for 2026, reflecting strong investor concerns about the company's future prospects.
- CEO Outlook: CEO Amanda Baldwin stated that despite the challenges, the company enters 2026 with a clear path forward and plans to adopt a more balanced and sustainable approach to investment and growth to navigate market changes.
See More
Olaplex Q4 Earnings Beat Expectations with Revenue Growth
- Earnings Highlights: Olaplex reported Q4 non-GAAP EPS of $0.01, in line with expectations, while revenue reached $105.12 million, reflecting a 4.4% year-over-year increase and beating market expectations by $0.77 million, demonstrating the company's resilience in a competitive hair care market.
- Channel Performance Variance: Among sales channels, professional segment revenue surged 18.9% to $36.8 million, and direct-to-consumer sales rose 6.6% to $43.6 million, while specialty retail saw a decline of 14.5% to $24.7 million, indicating shifts in consumer preferences and market dynamics.
- Fiscal 2026 Outlook: Olaplex projects revenue for FY26 between $414 million and $435 million, with adjusted gross profit margins expected to be between 71% and 72%, and adjusted EBITDA margins between 21% and 22%, reflecting the company's confidence in future growth.
- Acquisition Rumors Impact: Olaplex's stock price surged following reports of a takeover offer from Germany's Henkel, and the market's focus on this potential acquisition could further bolster investor confidence and enhance the company's market position in the hair care industry.
See More
Surge in Options Trading Volume for Okta and PBF Energy
- Okta Options Volume: Okta Inc saw options trading volume of 29,509 contracts, equating to approximately 3 million shares, which represents about 85.8% of its average daily trading volume of 3.4 million shares over the past month, indicating strong market interest in its future performance.
- High-Frequency Contracts: Notably, the $100 strike put option expiring on September 18, 2026, has seen 2,500 contracts traded today, representing around 250,000 underlying shares, suggesting investor expectations of a potential price decline.
- PBF Energy Options Activity: PBF Energy Inc's options trading volume reached 24,968 contracts, approximately 2.5 million shares, which is about 81.4% of its average daily trading volume of 3.1 million shares over the past month, reflecting sustained investor interest in the company.
- Bullish Call Options: Particularly, the $44 strike call option expiring on March 20, 2026, has recorded 8,570 contracts traded today, representing approximately 857,000 underlying shares, indicating a bullish sentiment regarding PBF's future performance.
See More
Olaplex Set to Report Earnings, Market Expects Growth
- Earnings Preview: Olaplex is set to report earnings this Thursday before market open, with the market expecting a 3.2% year-on-year revenue growth, contrasting sharply with the 9.8% decline recorded in the same quarter last year, indicating the company's potential for recovery amidst challenges.
- Revenue Performance: Last quarter, Olaplex reported revenues of $114.6 million, down 3.8% year-on-year, yet it exceeded analysts' expectations, showcasing the company's resilience in profitability, particularly with impressive beats in EBITDA and EPS estimates.
- Market Reaction: Despite a 5.1% decline in Olaplex's stock price over the past month, analysts remain optimistic about its future performance, as most have reaffirmed their revenue estimates in the last 30 days, reflecting confidence in the company's stability.
- Industry Comparison: In the personal care sector, e.l.f. Beauty and USANA reported strong revenue growths of 37.8% and 5.9%, respectively, although both saw stock price declines post-results, providing a benchmark for Olaplex's market performance.
See More
Olaplex Options Trading Analysis
- Options Selling Risks: Selling puts on Olaplex does not provide the same upside potential as owning shares, as the seller only acquires shares if the contract is exercised, and unless shares fall 33.8%, the only gain is the 40.6% annualized return from the premium.
- Historical Volatility Insight: With a historical volatility of 66%, analyzing Olaplex's stock alongside fundamental factors can help investors assess whether selling puts at the $1 strike price is a worthwhile risk for potential rewards.
- Market Trading Dynamics: On Tuesday afternoon, the put volume among S&P 500 components reached 1.01 million contracts, matching call volume, resulting in a put:call ratio of 0.71, indicating higher demand for puts than the long-term median of 0.65.
- Investor Sentiment Shift: The current higher-than-expected put buying suggests increased investor concern over Olaplex's future stock price decline, which could negatively impact overall market confidence in the company.
See More
Olaplex Holdings Reports Q4 2025 Earnings and Strategic Outlook
- Stable Financial Performance: Olaplex reported full-year net sales of $423 million for 2025, remaining flat year-over-year, yet fourth-quarter sales increased by 4.3% to $105.1 million, indicating strong holiday performance and reflecting the company's stability and potential for future growth.
- Successful Brand Relaunch: The comprehensive brand relaunch resulted in a 7% increase in brand awareness, a 3% improvement in consumer sentiment, and an upward trend in purchase intent, with earned media value rising 14% year-over-year, showcasing Olaplex's effective market promotion and strengthening its position in the competitive beauty industry.
- Strategic Acquisition for Innovation: The acquisition of Purvala Bioscience allows Olaplex to access transformative bio-inspired technologies and enter additional health and beauty verticals, broadening its product line and laying the groundwork for future innovations.
- Cautious Future Outlook: The company expects net sales in 2026 to range from a decline of 2% to an increase of 3%, with adjusted gross profit margins between 71% and 72%, and while facing complexities from packaging rollouts and innovation pipelines, management remains optimistic about sales recovery and emphasizes the effectiveness of marketing investments.
See More
Olaplex's 2026 Sales Guidance Downgrade Triggers Stock Plunge
- Sales Guidance Downgrade: Olaplex (OLPX) has projected FY26 sales between $414 million and $435 million, with a midpoint of $424.5 million, which falls short of the consensus estimate of $432 million, indicating management's pessimistic outlook for Q1 sales performance.
- EBITDA Margin Warning: The company cautioned that the adjusted EBITDA margin for Q1 will trend significantly below the expected full-year rate, primarily due to front-loaded marketing expenditures that could impact overall profitability.
- Stock Price Plunge: Shares of Olaplex (OLPX) plummeted 21.9% in Thursday morning trading, erasing most of the gains built up for 2026, reflecting strong investor concerns about the company's future prospects.
- CEO Outlook: CEO Amanda Baldwin stated that despite the challenges, the company enters 2026 with a clear path forward and plans to adopt a more balanced and sustainable approach to investment and growth to navigate market changes.
See More
Olaplex Q4 Earnings Beat Expectations with Revenue Growth
- Earnings Highlights: Olaplex reported Q4 non-GAAP EPS of $0.01, in line with expectations, while revenue reached $105.12 million, reflecting a 4.4% year-over-year increase and beating market expectations by $0.77 million, demonstrating the company's resilience in a competitive hair care market.
- Channel Performance Variance: Among sales channels, professional segment revenue surged 18.9% to $36.8 million, and direct-to-consumer sales rose 6.6% to $43.6 million, while specialty retail saw a decline of 14.5% to $24.7 million, indicating shifts in consumer preferences and market dynamics.
- Fiscal 2026 Outlook: Olaplex projects revenue for FY26 between $414 million and $435 million, with adjusted gross profit margins expected to be between 71% and 72%, and adjusted EBITDA margins between 21% and 22%, reflecting the company's confidence in future growth.
- Acquisition Rumors Impact: Olaplex's stock price surged following reports of a takeover offer from Germany's Henkel, and the market's focus on this potential acquisition could further bolster investor confidence and enhance the company's market position in the hair care industry.
See More
Surge in Options Trading Volume for Okta and PBF Energy
- Okta Options Volume: Okta Inc saw options trading volume of 29,509 contracts, equating to approximately 3 million shares, which represents about 85.8% of its average daily trading volume of 3.4 million shares over the past month, indicating strong market interest in its future performance.
- High-Frequency Contracts: Notably, the $100 strike put option expiring on September 18, 2026, has seen 2,500 contracts traded today, representing around 250,000 underlying shares, suggesting investor expectations of a potential price decline.
- PBF Energy Options Activity: PBF Energy Inc's options trading volume reached 24,968 contracts, approximately 2.5 million shares, which is about 81.4% of its average daily trading volume of 3.1 million shares over the past month, reflecting sustained investor interest in the company.
- Bullish Call Options: Particularly, the $44 strike call option expiring on March 20, 2026, has recorded 8,570 contracts traded today, representing approximately 857,000 underlying shares, indicating a bullish sentiment regarding PBF's future performance.
See More
Olaplex Set to Report Earnings, Market Expects Growth
- Earnings Preview: Olaplex is set to report earnings this Thursday before market open, with the market expecting a 3.2% year-on-year revenue growth, contrasting sharply with the 9.8% decline recorded in the same quarter last year, indicating the company's potential for recovery amidst challenges.
- Revenue Performance: Last quarter, Olaplex reported revenues of $114.6 million, down 3.8% year-on-year, yet it exceeded analysts' expectations, showcasing the company's resilience in profitability, particularly with impressive beats in EBITDA and EPS estimates.
- Market Reaction: Despite a 5.1% decline in Olaplex's stock price over the past month, analysts remain optimistic about its future performance, as most have reaffirmed their revenue estimates in the last 30 days, reflecting confidence in the company's stability.
- Industry Comparison: In the personal care sector, e.l.f. Beauty and USANA reported strong revenue growths of 37.8% and 5.9%, respectively, although both saw stock price declines post-results, providing a benchmark for Olaplex's market performance.
See More
Olaplex Options Trading Analysis
- Options Selling Risks: Selling puts on Olaplex does not provide the same upside potential as owning shares, as the seller only acquires shares if the contract is exercised, and unless shares fall 33.8%, the only gain is the 40.6% annualized return from the premium.
- Historical Volatility Insight: With a historical volatility of 66%, analyzing Olaplex's stock alongside fundamental factors can help investors assess whether selling puts at the $1 strike price is a worthwhile risk for potential rewards.
- Market Trading Dynamics: On Tuesday afternoon, the put volume among S&P 500 components reached 1.01 million contracts, matching call volume, resulting in a put:call ratio of 0.71, indicating higher demand for puts than the long-term median of 0.65.
- Investor Sentiment Shift: The current higher-than-expected put buying suggests increased investor concern over Olaplex's future stock price decline, which could negatively impact overall market confidence in the company.
See More
